Previous article
Bleeding Risk With Atrial Fibrillation, Prostate Cancer Screening, Alzheimer Disease, Concussion, Melanoma, Rheumatoid Arthritis
Oct 2025
Next article
Antidepressants vs Placebo for Moderate to Severe Generalized Anxiety Disorder
Medicine by the Numbers

Glucagon-Like Peptide-1 Receptor Agonists for People With Chronic Kidney Disease and Diabetes

Joy Elliott, DO
D. Jason Frasca, DO

American Family Physician. 2025;112(4):369-370.

Author disclosure: No relevant financial relationships.

JOY ELLIOTT, DO, FACOFP, Virginia Commonwealth University Riverside Family Medicine Residency, Newport News

D. JASON FRASCA, DO, FAAFP, Virginia Commonwealth University Riverside Family Medicine Residency, Newport News

Address correspondence to D. Jason Frasca, DO, FAAFP, at Jason.frasca@hotmail.com.

Author disclosure: No relevant financial relationships.

  1. 1.Kidney Disease: Improving Global Outcomes Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1-S127.
  2. 2.Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
  3. 3.Kidney Disease: Improving Global Outcomes Diabetes Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150.
  4. 4.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2022. Diabetes Care. 2022;45(suppl 1):S125-S143.
  5. 5.Natale P, Green SC, Tunnicliffe DJ, et al. Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2025(2):CD015849.

Copyright ©2026 MD Aware, LLC (theNNT.com). Used with permission.

This series is coordinated by Christopher W. Bunt, MD, AFP assistant medical editor, and the NNT Group.

A collection of Medicine by the Numbers published in AFP is available at https:// www.aafp.org/afp/mbtn.

Previous article
Bleeding Risk With Atrial Fibrillation, Prostate Cancer Screening, Alzheimer Disease, Concussion, Melanoma, Rheumatoid Arthritis
Oct 2025
Next article
Antidepressants vs Placebo for Moderate to Severe Generalized Anxiety Disorder

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.